{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:50:07Z","timestamp":1783608607403,"version":"3.55.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T00:00:00Z","timestamp":1460764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13318-016-0335-4","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T07:49:07Z","timestamp":1460792947000},"page":"469-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical Drug\u2013Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives"],"prefix":"10.1007","volume":"41","author":[{"given":"Suresh P.","family":"Sulochana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzeeb","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraj V.","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Mullangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuggehally R.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"issue":"9","key":"335_CR1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/003655298750026912","volume":"33","author":"BL Slomiany","year":"1998","unstructured":"Slomiany BL, Piotrowski J, Slomiany A. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol. 1998;33(9):916\u201322.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"335_CR2","first-page":"595","volume":"87","author":"BL Slomiany","year":"1992","unstructured":"Slomiany BL, Piotrowski J, Slomiany A. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases. Am J Gastroenterol. 1992;87(5):595\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"6A","key":"335_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(89)90149-6","volume":"86","author":"C Tasman-Jones","year":"1989","unstructured":"Tasman-Jones C, Morrison G, Thomsen L, Vanderwee M. Sucralfate interactions with gastric mucus. Am J Med. 1989;86(6A):5\u20139.","journal-title":"Am J Med"},{"issue":"5","key":"335_CR4","first-page":"512","volume":"32","author":"K Steiner","year":"1982","unstructured":"Steiner K, B\u00fchring KU, Faro HP, Garbe A, Nowak H. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals. Arzneimittelforschung. 1982;32(5):512\u20138.","journal-title":"Arzneimittelforschung"},{"key":"335_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/00365528609093831","volume":"125","author":"D Hollander","year":"1986","unstructured":"Hollander D, Tarnawski A, Gergely H. Protection against alcohol-induced gastric mucosal injury by aluminum-containing compounds\u2014sucralfate, antacids, and aluminum sulfate. Scand J Gastroenterol Suppl. 1986;125:151\u20135.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"335_CR6","first-page":"7","volume":"140","author":"A Tarnawski","year":"1987","unstructured":"Tarnawski A, Hollander D, Gergely H. The mechanism of protective, therapeutic and prophylactic actions of sucralfate. Scand J Gastroenterol Suppl. 1987;140:7\u201313.","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"Suppl 2","key":"335_CR7","first-page":"111","volume":"3","author":"DH Giesing","year":"1981","unstructured":"Giesing DH, Bighley LD, Iles RL. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. J Clin Gastroenterol. 1981;3(Suppl 2):111\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"335_CR8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0016-5085(86)90865-6","volume":"90","author":"A Tarnawski","year":"1986","unstructured":"Tarnawski A, Hollander D, Krause WJ, Zipser RD, Stachura J, Gergely H. Does sucralfate affect the normal gastric mucosa? Histologic, ultrastructural, and functional assessment in the rat. Gastroenterology. 1986;90(4):893\u2013905.","journal-title":"Gastroenterology"},{"issue":"5","key":"335_CR9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF01296213","volume":"29","author":"DY Graham","year":"1984","unstructured":"Graham DY, Sackman JW, Giesing DH, Runser DJ. In vitro adsorption of bile salts and aspirin to sucralfate. Dig Dis Sci. 1984;29(5):402\u20136.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"335_CR10","first-page":"179","volume":"51","author":"BL Slomiany","year":"2000","unstructured":"Slomiany BL, Piotrowski J, Slomiany A. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate. J Physiol Pharmacol. 2000;51(2):179\u201392.","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"335_CR11","first-page":"69","volume":"51","author":"BL Slomiany","year":"2000","unstructured":"Slomiany BL, Piotrowski J, Slomiany A. Role of interleukin-4 in down-regulation of endothelin-1 during gastric ulcer healing: effect of sucralfate. J Physiol Pharmacol. 2000;51(1):69\u201383.","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"335_CR12","first-page":"126","volume":"19","author":"A Tarnawski","year":"2013","unstructured":"Tarnawski A, Ahluwalia A, Jones MK. Gastric cytoprotection beyond prostaglandins: cellular and molecular mechanisms of gastroprotective and ulcer healing actions of antacids. Curr Pharm Des. 2013;19(1):126\u201332.","journal-title":"Curr Pharm Des"},{"key":"335_CR13","unstructured":"http:\/\/www.drugs.com\/pro\/sucralfate-tablet.html . Accessed 11 Apr 2016."},{"key":"335_CR14","unstructured":"http:\/\/www.medindia.net\/drug-price\/sucralfate.htm . Accessed 11 Apr 2016."},{"issue":"1","key":"335_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5326\/JAAHA-MS-6213","volume":"52","author":"J Quimby","year":"2016","unstructured":"Quimby J, Lappin M. Evaluating sucralfate as a phosphate binder in normal cats and cats with chronic kidney disease. J Am Anim Hosp Assoc. 2016;52(1):8\u201312.","journal-title":"J Am Anim Hosp Assoc"},{"issue":"2","key":"335_CR16","first-page":"106","volume":"5","author":"A Hashemi","year":"2015","unstructured":"Hashemi A, Bahrololoumi Z, Khaksar Y, Saffarzadeh N, Neamatzade H, Foroughi E. Mouth-rinses for the prevention of chemotherapy induced oral mucositis in children: a systematic review. Iran J Ped Hematol Oncol. 2015;5(2):106\u201312.","journal-title":"Iran J Ped Hematol Oncol."},{"issue":"5","key":"335_CR17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1590\/S0102-865020150050000004","volume":"30","author":"CE Bonassa","year":"2015","unstructured":"Bonassa CE, Pereira JA, Campos FG, Rodrigues MR, Sato DT, Chaim FD, Martinez CA. Tissue content of sulfomucins and sialomucins in the colonic mucosa, without fecal stream, undergoing daily intervention with sucralfate. Acta Cir Bras. 2015;30(5):328\u201338.","journal-title":"Acta Cir Bras."},{"issue":"6","key":"335_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5306\/wjco.v6.i6.272","volume":"6","author":"L Frazzoni","year":"2015","unstructured":"Frazzoni L, La Marca M, Guido A, Morganti AG, Bazzoli F, Fuccio L. Pelvic radiation disease: updates on treatment options. World J Clin Oncol. 2015;6(6):272\u201380.","journal-title":"World J Clin Oncol."},{"issue":"4","key":"335_CR19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jan.12867","volume":"72","author":"M Manzi Nde","year":"2016","unstructured":"Manzi Nde M, Silveira RC, Reis PE. Prophylaxis for mucositis induced by ambulatory chemotherapy: systematic review. J Adv Nurs. 2016;72(4):735\u201346.","journal-title":"J Adv Nurs."},{"issue":"2","key":"335_CR20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/0300060514559791","volume":"43","author":"J Jin","year":"2015","unstructured":"Jin J, Li X, Xing L, Chang Y, Wu L, Jin Z, Su X, Bai Y, Zheng Y, Jiang Y, Zhao X, Lu L, Gao Q. Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia. J Int Med Res. 2015;43(2):204\u201316.","journal-title":"J Int Med Res"},{"issue":"3B","key":"335_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0002-9343(87)90833-3","volume":"83","author":"AI Stern","year":"1987","unstructured":"Stern AI, Ward F, Hartley G. Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa. Am J Med. 1987;83(3B):83\u20135.","journal-title":"Am J Med"},{"key":"335_CR22","first-page":"36","volume":"6","author":"AS Ridolfo","year":"1980","unstructured":"Ridolfo AS, Crabtree RE, Johnson DW, Rockhold FW. Gastrointestinal microbleeding: comparisons between benoxaprofen and other nonsteroidal antiinflammatory agents. J Rheumatol Suppl. 1980;6:36\u201347.","journal-title":"J Rheumatol Suppl"},{"key":"335_CR23","first-page":"13","volume":"32","author":"K Brune","year":"1991","unstructured":"Brune K, Beck WS. Towards safer nonsteroidal anti-inflammatory drugs. Agents Actions Suppl. 1991;32:13\u201325.","journal-title":"Agents Actions Suppl"},{"issue":"2","key":"335_CR24","first-page":"219","volume":"27","author":"Y See","year":"1998","unstructured":"See Y, Ng SC, Tho KS, Teo SK. Are antacids necessary as routine prescriptives with non-steroidal anti-inflammatory drugs? Ann Acad Med Singap. 1998;27(2):219\u201322.","journal-title":"Ann Acad Med Singap"},{"issue":"8","key":"335_CR25","first-page":"797","volume":"41","author":"W Ungeth\u00fcm","year":"1991","unstructured":"Ungeth\u00fcm W. Study on the interaction between sucralfate and diclofenac\/piroxicam in healthy volunteers. Arzneimittelforschung. 1991;41(8):797\u2013800.","journal-title":"Arzneimittelforschung"},{"issue":"3B","key":"335_CR26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(87)90831-X","volume":"83","author":"G Caille","year":"1987","unstructured":"Caille G, du Souich P, Gervais P, Besner JG, Vezina M. Effects of concurrent sucralfate administration on pharmacokinetics of naproxen. Am J Med. 1987;83(3B):67\u201373.","journal-title":"Am J Med"},{"issue":"2","key":"335_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bdd.2510080208","volume":"8","author":"G Caill\u00e9","year":"1987","unstructured":"Caill\u00e9 G, Du Souich P, Gervais P, Besner JG. Single dose pharmacokinetics of ketoprofen, indomethacin, and naproxen taken alone or with sucralfate. Biopharm Drug Dispos. 1987;8(2):173\u201383.","journal-title":"Biopharm Drug Dispos"},{"key":"335_CR28","doi-asserted-by":"crossref","unstructured":"Caill\u00e9 G, du Souich P, Besner JG, Gervais P, V\u00e9zina M. Effects of food and sucralfate on the pharmacokinetics of naproxen and ketoprofen in humans. Am J Med. 1989 9;86(6A):38\u201344.","DOI":"10.1016\/0002-9343(89)90155-1"},{"issue":"10","key":"335_CR29","first-page":"773","volume":"9","author":"D Lapontaine","year":"1990","unstructured":"Lapontaine D, Mailhot C, Vermeulen M, Bissonnette B, Lambert C. Influence of chewable sucralfate or a standard meal on the bioavailability of naproxen. Clin Pharm. 1990;9(10):773\u20137.","journal-title":"Clin Pharm."},{"issue":"12","key":"335_CR30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/009127009203201209","volume":"32","author":"MA Levine","year":"1992","unstructured":"Levine MA, Walker SE, Paton TW. The effect of food or sucralfate on the bioavailability of S(+) and R(\u2212) enantiomers of ibuprofen. J Clin Pharmacol. 1992;32(12):1110\u20134.","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 2","key":"335_CR31","first-page":"103","volume":"3","author":"R Nagashima","year":"1981","unstructured":"Nagashima R. Development and characteristics of sucralfate. J Clin Gastroenterol. 1981;3(Suppl 2):103\u201310.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"335_CR32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/clpt.1985.101","volume":"37","author":"AR Marano","year":"1985","unstructured":"Marano AR, Caride VJ, Prokop EK, Troncale FJ, McCallum RW. Effect of sucralfate and an aluminum hydroxide gel on gastric emptying of solids and liquids. Clin Pharmacol Ther. 1985;37(6):629\u201332.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"335_CR33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/AAC.33.1.99","volume":"33","author":"SH Parpia","year":"1989","unstructured":"Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ. Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrob Agents Chemother. 1989;33(1):99\u2013102.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"335_CR34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.38.2.248","volume":"38","author":"P Lehto","year":"1994","unstructured":"Lehto P, Kivist\u00f6 KT. Effect of sucralfate on absorption of norfloxacin and ofloxacin. Antimicrob Agents Chemother. 1994;38(2):248\u201351.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"335_CR35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/AAC.34.5.931","volume":"34","author":"JC Garrelts","year":"1990","unstructured":"Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC. Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrob Agents Chemother. 1990;34(5):931\u20133.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"335_CR36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/106002809102500601","volume":"25","author":"AD Slooten Van","year":"1991","unstructured":"Van Slooten AD, Nix DE, Wilton JH, Love JH, Spivey JM, Goldstein HR. Combined use of ciprofloxacin and sucralfate. DICP. 1991;25(6):578\u201382.","journal-title":"DICP."},{"issue":"7","key":"335_CR37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.1989.03430070049022","volume":"262","author":"JH Yuk","year":"1989","unstructured":"Yuk JH, Nightingale CN, Quintiliani R. Ciprofloxacin levels when receiving sucralfate. JAMA. 1989;262(7):901.","journal-title":"JAMA"},{"issue":"6","key":"335_CR38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/j.1875-9114.1989.tb04152.x","volume":"9","author":"DE Nix","year":"1989","unstructured":"Nix DE, Watson WA, Handy L, Frost RW, Rescott DL, Goldstein HR. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy. 1989;9(6):377\u201380.","journal-title":"Pharmacotherapy."},{"issue":"12","key":"335_CR39","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/AAC.36.12.2758","volume":"36","author":"TJ Lubowski","year":"1992","unstructured":"Lubowski TJ, Nightingale CH, Sweeney K, Quintiliani R. Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers. Antimicrob Agents Chemother. 1992;36(12):2758\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"335_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00193481","volume":"47","author":"J Kawakami","year":"1994","unstructured":"Kawakami J, Matsuse T, Kotaki H, et al. The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers. Eur J Clin Pharmacol. 1994;47(1):67\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"335_CR41","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/AAC.41.10.2196","volume":"41","author":"LJ Lee","year":"1997","unstructured":"Lee LJ, Hafkin B, Lee ID, Hoh J, Dix R. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Antimicrob Agents Chemother. 1997;41(10):2196\u2013200.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"335_CR42","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/AAC.41.8.1668","volume":"41","author":"JA Zix","year":"1997","unstructured":"Zix JA, Geerdes-Fenge HF, Rau M, et al. Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate. Antimicrob Agents Chemother. 1997;41(8):1668\u201372.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"335_CR43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2125.2000.00118.x","volume":"49","author":"M Kamberi","year":"2000","unstructured":"Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin. Br J Clin Pharmacol. 2000;49(2):98\u2013103.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"335_CR44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-200140001-00007","volume":"40","author":"H Stass","year":"2001","unstructured":"Stass H, Sch\u00fchly U, M\u00f6ller JG, Delesen H. Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. Clin Pharmacokinet. 2001;40(Suppl 1):49\u201355.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"335_CR45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/clpt.1994.168","volume":"56","author":"P Lehto","year":"1994","unstructured":"Lehto P, Kivist\u00f6 KT. Different effects of products containing metal ions on the absorption of lomefloxacin. Clin Pharmacol Ther. 1994;56(5):477\u201382.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"335_CR46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0924-8579(00)00187-4","volume":"15","author":"A Allen","year":"2000","unstructured":"Allen A, Bygate E, Faessel H, Isaac L, Lewis A. The effect of ferrous sulphate and sucralfate on the bioavailability of oral gemifloxacin in healthy volunteers. Int J Antimicrob Agents. 2000;15(4):283\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"14","key":"335_CR47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1056\/NEJM199110033251407","volume":"325","author":"DM McCarthy","year":"1991","unstructured":"McCarthy DM. Sucralfate. N Engl J Med. 1991;325(14):1017\u201325.","journal-title":"N Engl J Med"},{"key":"335_CR48","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.37.10.2173","volume":"37","author":"M Tanaka","year":"1993","unstructured":"Tanaka M, Kurata T, Fujisawa C, et al. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob Agents Chemother. 1993;37:2173\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"335_CR49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2125.1991.tb05526.x","volume":"31","author":"M Kara","year":"1991","unstructured":"Kara M, Hasinoff BB, McKay DW, Campbell NR. Clinical and chemical interactions between iron preparations and ciprofloxacin. Br J Clin Pharmacol. 1991;31(3):257\u201361.","journal-title":"Br J Clin Pharmacol"},{"key":"335_CR50","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/AAC.36.6.1219","volume":"36","author":"J Shimada","year":"1992","unstructured":"Shimada J, Shiba K, Oguma T, et al. Effect of antacid on absorption of the quinolone lomefloxacin. Antimicrob Agents Chemother. 1992;36:1219\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"335_CR51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/clpt.1992.138","volume":"52","author":"ME Lebsack","year":"1992","unstructured":"Lebsack ME, Nix D, Ryerson B, et al. Effect of gastric acidity on enoxacin absorption. Clin Pharmacol Ther. 1992;52:252\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"335_CR52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jps.2600751018","volume":"75","author":"G Mullersman","year":"1986","unstructured":"Mullersman G, Gotz VP, Russell WL, Derendorf H. Lack of clinically significant in vitro and in vivo interactions between ranitidine and sucralfate. J Pharm Sci. 1986;75(10):995\u20138.","journal-title":"J Pharm Sci"},{"issue":"12","key":"335_CR53","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jps.2600781204","volume":"78","author":"CK Shim","year":"1989","unstructured":"Shim CK, Hong JS. Inter- and intra-subject variations of ranitidine pharmacokinetics after oral administration to normal male subjects. J Pharm Sci. 1989;78(12):990\u20134.","journal-title":"J Pharm Sci"},{"issue":"6","key":"335_CR54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF00279987","volume":"40","author":"M Seibert-Grafe","year":"1991","unstructured":"Seibert-Grafe M, Pidgen A. Lack of effect of multiple dose sucralfate on the pharmacokinetics of roxatidine acetate. Eur J Clin Pharmacol. 1991;40(6):637\u20138.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"335_CR55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00607967","volume":"30","author":"H Albin","year":"1986","unstructured":"Albin H, Vincon G, Lalague MC, Couzigou P, Amouretti M. Effect of sucralfate on the bioavailability of cimetidine. Eur J Clin Pharmacol. 1986;30(4):493\u20134.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"335_CR56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2125.1986.tb02834.x","volume":"21","author":"R D\u2019Angio","year":"1986","unstructured":"D\u2019Angio R, Mayersohn M, Conrad KA, Bliss M. Cimetidine absorption in humans during sucralfate coadministration. Br J Clin Pharmacol. 1986;21(5):515\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"335_CR57","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/AAC.47.3.1129-1131.2003","volume":"47","author":"MW Pletz","year":"2003","unstructured":"Pletz MW, Preechachatchaval V, Bulitta J, Allewelt M, Burkhardt O, Lode H. ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate. Antimicrob Agents Chemother. 2003;47(3):1129\u201331.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"335_CR58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/j.1552-4604.1990.tb03436.x","volume":"30","author":"LG Miller","year":"1990","unstructured":"Miller LG, Prichard JG, White CA, Vytla B, Feldman S, Bowman RC. Effect of concurrent sucralfate administration on the absorption of erythromycin. J Clin Pharmacol. 1990;30(1):39\u201344.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"335_CR59","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/j.1552-4604.1986.tb02960.x","volume":"26","author":"PW Letendre","year":"1986","unstructured":"Letendre PW, Carlson JD, Seifert RD, Dietz AJ Jr, Dimmit D. Effect of sucralfate on the absorption and pharmacokinetics of chlorpropamide. J Clin Pharmacol. 1986;26(8):622\u20135.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"335_CR60","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/00970002042006010","volume":"42","author":"MN Rao","year":"2002","unstructured":"Rao MN, Mullangi R, Katneni K, et al. Lack of effect of sucralfate on the absorption and pharmacokinetics of rosiglitazone. J Clin Pharmacol. 2002;42(6):670\u20135.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"335_CR61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.38.2.326","volume":"38","author":"PL Carver","year":"1994","unstructured":"Carver PL, Berardi RR, Knapp MJ, et al. In vivo interaction of ketoconazole and sucralfate in healthy volunteers. Antimicrob Agents Chemother. 1994;38(2):326\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"335_CR62","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/AAC.35.9.1765","volume":"35","author":"SC Piscitelli","year":"1991","unstructured":"Piscitelli SC, Goss TF, Wilton JH, D\u2019Andrea DT, Goldstein H, Schentag JJ. Effects of ranitidine and sucralfate on ketoconazole bioavailability. Antimicrob Agents Chemother. 1991;35(9):1765\u201371.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"335_CR63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/AAC.38.2.319","volume":"38","author":"JD Hoeschele","year":"1994","unstructured":"Hoeschele JD, Roy AK, Pecoraro VL, Carver PL. In vitro analysis of the interaction between sucralfate and ketoconazole. Antimicrob Agents Chemother. 1994;38(2):319\u201325.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"335_CR64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/clpt.1986.26","volume":"39","author":"AH Lau","year":"1986","unstructured":"Lau AH, Chang CW, Schlesinger PK. Evaluation of a potential drug interaction between sucralfate and aspirin. Clin Pharmacol Ther. 1986;39(2):151\u20135.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"335_CR65","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/j.1552-4604.1991.tb03721.x","volume":"31","author":"DK Schneider","year":"1991","unstructured":"Schneider DK, Gannon RH, Sweeney KR, DeFusco PA. Influence of sucralfate on trilisate bioavailability. J Clin Pharmacol. 1991;31(4):377\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"335_CR66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bod.2510090306","volume":"9","author":"RO Day","year":"1988","unstructured":"Day RO, Furst DE, Dromgoole SH, Paulus HE. Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers. Biopharm Drug Dispos. 1988;9(3):273\u201383.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"335_CR67","first-page":"42","volume":"82","author":"JG Gambertoglio","year":"1987","unstructured":"Gambertoglio JG, Romac DR, Yong CL, Birnbaum J, Lizak P, Amend WJ Jr. Lack of effect of sucralfate on prednisone bioavailability. Am J Gastroenterol. 1987;82(1):42\u20135.","journal-title":"Am J Gastroenterol"},{"key":"335_CR68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archinte.1992.00400130181024","volume":"152","author":"AD Sperber","year":"1992","unstructured":"Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med. 1992;152:183\u20134.","journal-title":"Arch Intern Med"},{"key":"335_CR69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(94)90303-4","volume":"97","author":"Y Liel","year":"1994","unstructured":"Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994;97:363\u20135.","journal-title":"Am J Med"},{"issue":"1","key":"335_CR70","first-page":"58","volume":"7","author":"KA Cantral","year":"1988","unstructured":"Cantral KA, Schaaf LJ, Jungnickel PW, Monsour HP. Effect of sucralfate on theophylline absorption in healthy volunteers. Clin Pharm. 1988;7(1):58\u201361.","journal-title":"Clin Pharm."},{"issue":"2","key":"335_CR71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1016487507420","volume":"4","author":"AH Hikal","year":"1987","unstructured":"Hikal AH, Walker LA, Ramachandran T. In vitro and in vivo interactions of furosemide and sucralfate. Pharm Res. 1987;4(2):171\u20132.","journal-title":"Pharm Res"},{"issue":"3","key":"335_CR72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2125.1985.tb05067.x","volume":"20","author":"HL Smart","year":"1985","unstructured":"Smart HL, Somerville KW, Williams J, Richens A, Langman MJ. The effects of sucralfate upon phenytoin absorption in man. Br J Clin Pharmacol. 1985;20(3):238\u201340.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"335_CR73","first-page":"433","volume":"34","author":"ME Moraes","year":"1996","unstructured":"Moraes ME, Pierossi Mde A, Moraes MO, et al. Short-term sucralfate administration does not alter the absorption of metronidazole in healthy male volunteers. Int J Clin Pharmacol Ther. 1996;34(10):433\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3 Pt B","key":"335_CR74","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.ejpb.2013.09.009","volume":"85","author":"A Kambayashi","year":"2013","unstructured":"Kambayashi A, Blume H, Dressman J. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. Eur J Pharm Biopharm. 2013;85(3 Pt B):1337\u201347.","journal-title":"Eur J Pharm Biopharm."},{"issue":"2","key":"335_CR75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2011.10.050","volume":"423","author":"Y Okuda","year":"2012","unstructured":"Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Further improvement of orally disintegrating tablets using micronized ethylcellulose. Int J Pharm. 2012;423(2):351\u20139.","journal-title":"Int J Pharm"},{"issue":"6","key":"335_CR76","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/1567201812666150310151238","volume":"12","author":"AM Elwerfalli","year":"2015","unstructured":"Elwerfalli AM, Ghanchi Z, Rashid F, Alany RG, ElShaer A. New generation of orally disintegrating tablets for sustained drug release: a propitious outlook. Curr Drug Deliv. 2015;12(6):652\u201367.","journal-title":"Curr Drug Deliv"},{"issue":"6","key":"335_CR77","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/156720181006131125150249","volume":"10","author":"H Kathpalia","year":"2013","unstructured":"Kathpalia H, Gupte A. An introduction to fast dissolving oral thin film drug delivery systems: a review. Curr Drug Deliv. 2013;10(6):667\u201384.","journal-title":"Curr Drug Deliv"},{"issue":"12","key":"335_CR78","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1002\/jps.24688","volume":"104","author":"A Abruzzo","year":"2015","unstructured":"Abruzzo A, Cerchiara T, Bigucci F, Gallucci MC, Luppi B. Mucoadhesive buccal tablets based on chitosan\/gelatin microparticles for delivery of propranolol hydrochloride. J Pharm Sci. 2015;104(12):4365\u201372.","journal-title":"J Pharm Sci"},{"issue":"11","key":"335_CR79","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1248\/cpb.c15-00250","volume":"63","author":"BS Patil","year":"2015","unstructured":"Patil BS, Mahajan HS, Surana SJ. Development of suppositories containing flutamide-loaded alginate-tamarind microparticles for rectal administration: in vitro and in vivo studies. Chem Pharm Bull (Tokyo). 2015;63(11):851\u20137.","journal-title":"Chem Pharm Bull (Tokyo)."},{"issue":"1","key":"335_CR80","first-page":"37","volume":"67","author":"M Dal Zorro","year":"2012","unstructured":"Dal Zorro M, Franceschinis E, Punchina A, Realdon N. Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories. Pharmazie. 2012;67(1):37\u201345.","journal-title":"Pharmazie."},{"key":"335_CR81","first-page":"689","volume":"77","author":"JP Lacz","year":"1982","unstructured":"Lacz JP, Drees D, Browne R. The effect of sucralfate on the absorption of cimetidine and other drugs in dogs. Am J Gastroenterol. 1982;77:689.","journal-title":"Am J Gastroenterol"},{"key":"335_CR82","first-page":"1108","volume":"82","author":"JP Lacz","year":"1982","unstructured":"Lacz JP, Groschang AG, Giesing DH, Browne RK. The effect of sucralfate on drug absorption in dogs. Gastroenterology. 1982;82:1108.","journal-title":"Gastroenterology"},{"issue":"5","key":"335_CR83","first-page":"261","volume":"6","author":"WA Ritschel","year":"1984","unstructured":"Ritschel WA, Banerjee PS, Koch HP, Czeijka M. Cimetidine-sucralfate drug interaction. Methods Find Exp Clin Pharmacol. 1984;6(5):261\u20133.","journal-title":"Methods Find Exp Clin Pharmacol"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-016-0335-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0335-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T17:34:30Z","timestamp":1692293670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-016-0335-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["335"],"URL":"https:\/\/doi.org\/10.1007\/s13318-016-0335-4","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}